Additionally, the authors found that HERV-K dUTPase treated PAECs displayed increased vulnerability to apoptosis in an IL-6 independent manner in response to serum withdrawal, a hallmark of PAH PAECs. This evidence concerns the gene IL6 and pulmonary arterial hypertension.